| Quality by design: concepts for ANDAs RA Lionberger, SL Lee, LM Lee, A Raw, LX Yu The AAPS journal 10, 268-276, 2008 | 502 | 2008 |
| Applications of process analytical technology to crystallization processes XY Lawrence, RA Lionberger, AS Raw, R D'Costa, H Wu, AS Hussain Advanced drug delivery reviews 56 (3), 349-369, 2004 | 421 | 2004 |
| Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products RK Chang, A Raw, R Lionberger, L Yu The AAPS journal 15, 41-52, 2013 | 413 | 2013 |
| Bioequivalence approaches for highly variable drugs and drug products SH Haidar, B Davit, ML Chen, D Conner, LM Lee, QH Li, R Lionberger, ... Pharmaceutical research 25, 237-241, 2008 | 251 | 2008 |
| High frequency modulus of hard sphere colloids RA Lionberger, WB Russel Journal of Rheology 38 (6), 1885-1908, 1994 | 241 | 1994 |
| FDA critical path initiatives: opportunities for generic drug development RA Lionberger The AAPS journal 10, 103-109, 2008 | 147 | 2008 |
| Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration BM Davit, ML Chen, DP Conner, SH Haidar, S Kim, CH Lee, ... The AAPS journal 14, 915-924, 2012 | 142 | 2012 |
| Utility of physiologically based absorption modeling in implementing quality by design in drug development X Zhang, RA Lionberger, BM Davit, LX Yu The AAPS journal 13, 59-71, 2011 | 136 | 2011 |
| Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs B Hens, Y Tsume, M Bermejo, P Paixao, MJ Koenigsknecht, JR Baker, ... Molecular pharmaceutics 14 (12), 4281-4294, 2017 | 129 | 2017 |
| In Vitro and In Vivo Characterizations of Pegylated Liposomal Doxorubicin W Jiang, R Lionberger, LX Yu Bioanalysis 3 (3), 333-344, 2011 | 120 | 2011 |
| Generic development of topical dermatologic products, part II: quality by design for topical semisolid products RK Chang, A Raw, R Lionberger, L Yu The AAPS journal 15, 674-683, 2013 | 106 | 2013 |
| Pharmacokinetics-based approaches for bioequivalence evaluation of topical dermatological drug products SG Raney, TJ Franz, PA Lehman, R Lionberger, ML Chen Clinical pharmacokinetics 54, 1095-1106, 2015 | 104 | 2015 |
| Novel bioequivalence approach for narrow therapeutic index drugs LX Yu, W Jiang, X Zhang, R Lionberger, F Makhlouf, DJ Schuirmann, ... Clinical Pharmacology & Therapeutics 97 (3), 286-291, 2015 | 97 | 2015 |
| Current challenges in bioequivalence, quality, and novel assessment technologies for topical products A Yacobi, VP Shah, ED Bashaw, E Benfeldt, B Davit, D Ganes, T Ghosh, ... Pharmaceutical research 31, 837-846, 2014 | 97 | 2014 |
| Effect of Device Design on the In Vitro Performance and Comparability for Capsule-Based Dry Powder Inhalers J Shur, S Lee, W Adams, R Lionberger, J Tibbatts, R Price The AAPS journal 14, 667-676, 2012 | 96 | 2012 |
| The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluation W Jiang, S Kim, X Zhang, RA Lionberger, BM Davit, DP Conner, ... International journal of pharmaceutics 418 (2), 151-160, 2011 | 95 | 2011 |
| A Smoluchowski theory with simple approximations for hydrodynamic interactions in concentrated dispersions RA Lionberger, WB Russel Journal of Rheology 41 (2), 399-425, 1997 | 95 | 1997 |
| Generic lamotrigine versus brand‐name Lamictal bioequivalence in patients with epilepsy: a field test of the FDA bioequivalence standard TY Ting, W Jiang, R Lionberger, J Wong, JW Jones, MA Kane, ... Epilepsia 56 (9), 1415-1424, 2015 | 94 | 2015 |
| Development of performance matrix for generic product equivalence of acyclovir topical creams YSR Krishnaiah, X Xu, Z Rahman, Y Yang, U Katragadda, R Lionberger, ... International journal of pharmaceutics 475 (1-2), 110-122, 2014 | 94 | 2014 |
| Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium JPF Bai, E Hausman, R Lionberger, X Zhang Molecular pharmaceutics 9 (12), 3495-3505, 2012 | 89 | 2012 |
